FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Recombinant Construct: P{GD11667}
Open Close
General Information
Symbol
P{GD11667}
FlyBase ID
FBtp0025102
Feature type
transgenic_transposable_element
Component Allele(s)
amlsGD11667
CG42306GD11667
Size
Expression Data
Associated insertion(s)
3 available
Molecular map
Description and Uses
Construct components
Component
Use(s)
Marker(s)
w+mC
Component allele amlsGD11667
Transgenic product class
RNAi_reagent
(Dickson et al., 2007.7.18)
Component
Use(s)
Regulatory region(s)
UASt
Encoded product / tool
dsRNA-GD11667
Description

UASt regulatory sequences drive expression of an inverted repeat.

(Dickson et al., 2007.7.18)
Component allele CG42306GD11667
Transgenic product class
RNAi_reagent
(Dickson et al., 2007.7.18)
Component
Use(s)
Regulatory region(s)
UASt
Encoded product / tool
dsRNA-GD11667
Description

UASt regulatory sequences drive expression of an inverted repeat.

(Dickson et al., 2007.7.18)
Sequence Data
Sequence (FB)
Associated Sequence Data
DDBJ / EMBL / GenBank
DNA Sequence
Extent
Segments and Size
Total Size
Left end
Right end
 
Segments
Num
Orientation
Symbol
Reference
Phenotypic Data
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Progenitors and Descendants
progenitor(s)
descendant(s)
Comments

Expression under the control of Scer\GAL41407 results in shorter neuroblast lineages (less daughter cells per neuroblast) in the larval brain compared to controls.

(Neumüller et al., 2011)

Expression under the control of Scer\GAL4pnr-MD237 may result in semi-lethality, depending on the insertion line used.

(Mummery-Widmer et al., 2009)

Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 100% or 90-100% of the Scer\GAL4pnr-MD237-expressing area of the notum, depending on the insertion line used.

(Mummery-Widmer et al., 2009)

Expression of P{GD11667} under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) results in viable flies.

(Neely et al., 2010)

Adults expressing P{GD11667} under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.

(Neely et al., 2010)

Expression of P{GD11667} under the control of the cardioblast-specific Scer\GAL4tin.CΔ4 driver results in viable flies.

(Neely et al., 2010)

Depending on the insertion line used, expression under the control of Scer\GAL4Mef2.PR can result in flightless flies or adult/pharate lethality.

(Schnorrer et al., 2010)

Expression under the control of Scer\GAL4Mef2.PR results in irregular adult indirect flight muscles.

(Schnorrer et al., 2010)

Expression under the control of Scer\GAL4Mef2.PR results in frayed myofibrils in the adult indirect flight muscles.

(Schnorrer et al., 2010)

Expression under the control of Scer\GAL4Mef2.PR results in sarcomeres with broadened Z-lines in the adult indirect flight muscles.

(Schnorrer et al., 2010)
Stocks (1)
Stocks containing insertion(s) of this recombinant construct
VDRC
v38998
w1118; P{GD11667}v38998/CyO
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (3)
Reported As
Symbol Synonym
Gint3-RNAi
(Martin et al., 2021)
P{GD11667}
(Dickson et al., 2007.7.18, FlyBase, 1996-)
UAS-alsRNAi
(Reim et al., 2014)
Secondary FlyBase IDs
    References (11)